HPAPIHigh Potency Active Pharmaceutical Ingredients
References in periodicals archive ?
Chapter 5 provides a detailed analysis of CMOs focussed in the HPAPI market.
Unlike APIs, HPAPIs are Mainly Manufactured in Developed Countries 6.
Read the full report: HPAPIs and Cytotoxic Drugs Manufacturing Market, 2014 - 2024 https://www.
4 The Contract HPAPI Manufacturing Submarket 2013-2023 3.
With the increasing use of HPAPIs in drug discovery and development, this new service augments WuXi's ability to provide highly efficient and cost-effective solutions for our partners worldwide," said Dr.
Oncology therapeutics including ADCs and HPAPIs (Highly Potent Active Pharmaceutical Ingredients) represent one of the fasting growing segments of the pharmaceutical industry.
HPAPI market by type of synthesis has been covered in this report providing their estimates and forecast from 2012 to 2018.
In addition, favorable regulations and healthcare reforms for the commercialization and R&D of novel HPAPI are expected to drive market growth during forecast period.
The additional 51,000 sq ft, which complements the company's 63,000 sq ft site in Madison, houses reactors capable of producing HPAPI batch sizes of up to 4000 L and will support pharmaceutical manufacturers with their Phase III and commercial HPAPI needs.
An analysis of the market size of global HPAPI industry is provided on the basis of regions such as North America, Europe and Asia-Pacific and the market segmentation by revenue from innovator and generic HPAPI.
Designed to significantly increase production capacity for commercial scale High Potency Active Pharmaceutical Ingredients (HPAPIs), the project includes a new 45,000 sq ft manufacturing facility with reactors capable of producing HPAPI batch sizes up to 4000 litres.